相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
Stefano Toldo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury
Chen Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Masafumi Takahashi
INTERNATIONAL HEART JOURNAL (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
Targeting Interleukin-1 in Heart Disease
Benjamin W. Van Tassell et al.
CIRCULATION (2013)
The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β
Nathan A. Bracey et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Interleukin-1β induces a reversible cardiomyopathy in the mouse
Benjamin W. Van Tassell et al.
INFLAMMATION RESEARCH (2013)
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies
Susannah D. Brydges et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Cutting Edge: IL-6 Is a Marker of Inflammation with No Direct Role in Inflammasome-Mediated Mouse Models
Matthew D. McGeough et al.
JOURNAL OF IMMUNOLOGY (2012)
Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
Benjamin W. Van Tassell et al.
PLOS ONE (2012)
Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice
Sheri L. Bonar et al.
PLOS ONE (2012)
Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
Coert J. Zuurbier et al.
PLOS ONE (2012)
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Beckley K. Davis et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
Kristin A. D. Sauter et al.
CANCER BIOLOGY & THERAPY (2011)
TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation
D. V. Krysko et al.
CELL DEATH AND DIFFERENTIATION (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hal M. Hoffman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury
Yan Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Inflammasome and IL-1β-Mediated Disorders
Hal M. Hoffman et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice
Maciej Lech et al.
INTERNATIONAL IMMUNOLOGY (2010)
Pharmacologic Inhibition of Phosphoinositide 3-Kinase Gamma (PI3Kγ) Promotes Infarct Resorption and Prevents Adverse Cardiac Remodeling After Myocardial Infarction in Mice
Ignacio M. Seropian et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Pharmacologic Inhibition of Myeloid Differentiation Factor 88 (MyD88) Prevents Left Ventricular Dilation and Hypertrophy After Experimental Acute Myocardial Infarction in the Mouse
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia
Reut Fallach et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
Mihai G. Netea et al.
BLOOD (2009)
Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
Susannah D. Brydges et al.
IMMUNITY (2009)
INFLAMMASOMES ARE DIFFERENTIALLY EXPRESSED IN CARDIOVASCULAR AND OTHER TISSUES
Y. Yin et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2008)
Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease
Jane A. Mitchell et al.
JOURNAL OF ENDOCRINOLOGY (2007)
A role for caspase-1 in heart failure
Sabine Merkle et al.
CIRCULATION RESEARCH (2007)
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
AJ Chong et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Modulation of doxorubicin-induced cardiac dysfunction in Toll-like receptor-2-knockout mice
N Nozaki et al.
CIRCULATION (2004)
Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
T Shishido et al.
CIRCULATION (2003)
Inflammatory mediators and the failing heart - Past, present, and the foreseeable future
DL Mann
CIRCULATION RESEARCH (2002)
分享论文
